Evidence map›Paper›PMID 35854812›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2022

Isabella Maria Monteiro de Souza, Romulo Dias Novaes, Reggiani Vilela Gonçalves, Felipe Leonardo Bley Fialho, Diogo Teixeira Carvalho, Thiago Belarmino de Souza, Danielle Ferreira Dias, Stefânia Neiva Lavorato, Raquel Lopes Martins Souza, Marcos José Marques and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Isabella Maria Monteiro de SouzaInstitute of Biomedical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Romulo Dias NovaesInstitute of Biomedical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Reggiani Vilela GonçalvesDepartment of Animal Biology, Federal University of Viçosa, Viçosa, MG, Brazil.
Felipe Leonardo Bley FialhoInstitute of Chemistry, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Diogo Teixeira CarvalhoSchool of Pharmaceutical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Thiago Belarmino de SouzaSchool of Pharmacy, Federal University of Ouro Preto, Ouro Preto, MG, Brazil.
Danielle Ferreira DiasInstitute of Chemistry, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Stefânia Neiva LavoratoCenter of Biological Sciences and Health, Federal University of Western Bahia (Ufob), Barreiras, BA, Brazil.
Raquel Lopes Martins SouzaInstitute of Biomedical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Marcos José MarquesInstitute of Biomedical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.ORCID 0000-0003-3459-3169
Aline Pereira CastroInstitute of Biomedical Sciences, Federal University of Alfenas (Unifal), Alfenas, MG, Brazil.
Universidade Federal de Alfenas · BRUniversidade Federal de Lavras · BRUniversidade Federal de Ouro Preto · BRUniversidade Federal de Viçosa · BRUniversidade Federal do Oeste da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Eugenol shows both antibacterial and antiparasitic activities, suggesting that it might be evaluated as an option for the treatment of praziquantel-resistant schistosome. Methods: The Results: The compounds showed effective doses (ED Conclusion: Eugenol derivatives, mainly FB4 when compared to FB1 and FB9, seem to act more effectively on the integument of adult

Indexed as

EugenolMechanism of actionSchistosoma mansoniSchistosomiasis

Identifiers

PMID35854812
PMCPMC9258719
OpenAlexW4285122356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.